Merck wraps up $2.7bn acquisition of biopharmaceutical firm ArQule

Merck wraps up $2.7bn acquisition of biopharmaceutical firm ArQule

Source: 
Pharmaceutical Business Review
News Tags: 
snippet: 

Merck has completed the acquisition of US-based biopharmaceutical company ArQule in a deal valued at around $2.7bn.